Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan for F508del Cystic Fibrosis
NCT03206788Phase 2Terminated
- Sponsor
- University of Miami
- Start
- Nov 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cystic fibrosis (CF) comparing Losartan group with Placebo group (2 arms). Primary endpoint: Change in Nasal Potential Difference to Assess CFTR Activity at 12 weeks. Started Nov 2017; status: terminated.
02
Drugs
losartan
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT03206788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03206788.